From professional translators, enterprises, web pages and freely available translation repositories.
table
tabela
Last Update: 2017-04-06
Usage Frequency: 7
Quality:
an agreement should in any event be on the table.
v vsakem primeru bi morali skleniti sporazum.
Last Update: 2012-02-28
Usage Frequency: 2
Quality:
note table of launch events.
*arvid pallo russian archive institute (rgantd) tribute to arvid pallo.
Last Update: 2016-03-03
Usage Frequency: 1
Quality:
adverse event reactions for bivalirudin are listed by system organ class in table 1.
neželeni učinki bivalirudina so našteti po organskih sistemih v preglednici 1.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tables submitted in event no: 523924.
tabele predložene v ev. št. 523924.
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
the following table gives the chronology of events:
v naslednji razpredelnici je predstavljen časovni potek dogodkov:
Last Update: 2014-11-13
Usage Frequency: 1
Quality:
table 3: patients with outcome events in triton primary analysis
preglednica 3: bolniki z izidi v primarni analizi triton
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
22 adverse events reported in the esprit trial are listed in table 3.
22 tabela 3 prikazuje prijavljene neželene dogodke v raziskavi esprit.
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
table of measures available in the event of non-compliance with the code of conduct
tabela razpoložljivih ukrepov v primeru neskladnosti s pravili ravnanja
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
table 6: effects of riociguat in patent-1 on events of clinical worsening
preglednica 6: učinki riociguata v študiji patent-1 na klinično poslabšanje
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
table 11 summarises adjudicated bleeding events for the safety analysis set on-treatment period.
preglednica 11 povzema po strokovni presoji krvavitvene dogodke za analizo varnosti med obdobjem zdravljenja.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
table 1 recommended dose modifications and management for symptomatic ck elevations and muscle-related adverse events
preglednica 1 priporočene spremembe odmerkov in ukrepi v primerih simptomatskega zvišanja kreatin-kinaze in z mišicami povezanih neželenih učinkov
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
table 1: adverse events following administration of gardasil from clinical trials and post- marketing surveillance
preglednica 1: neželeni učinki po uporabi cepiva gardasil med kliničnimi preskušanji in spremljanjem v obdobju trženja
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
coadministration with enzyme inducers may increase the risk of adverse events and alt elevations (see table 2).
sočasna uporaba z induktorji encimov lahko poveča tveganje za neželene učinke in zvišanje alt (glejte preglednico 2).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
table 1 also includes additional adverse events which have been spontaneously reported during the post-marketing use of gardasil worldwide.
preglednica 1 vključuje tudi dodatne neželene učinke, o katerih so spontano poročali v obdobju trženja cepiva gardasil po vsem svetu.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
for laboratory abnormalities, very common events (1/10) not included in table 2 are also reported.
navedene so tudi zelo pogoste (1/10) laboratorijske nepravilnosti, ki niso vključene v preglednico 2.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
table 1: adverse reactions reported with vpriv observed in patients with type 1 gaucher disease italic text denotes post-marketing event.
tabela 1: neželeni učinki, o katerih so poročali pri uporabi zdravila vpriv, ki so jih opazili pri bolnikih z gaucherjevo boleznijo tipa 1.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
table 2 – analysis of overall bleeding events, kaplan-meier estimates at 12 months (plato)
preglednica 2. - analiza vseh dogodkov, povezanih s krvavitvami, kaplan-meierjeve ocene po 12 mesecih (plato)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the beneficial effect of selexipag was primarily attributable to a reduction in hospitalisation for pah and a reduction in other disease-progression events (table 1).
koristni učinek seleksipaga primarno pripisujejo zmanjšanju hospitalizacije zaradi pah in zmanjšanju drugih dogodkov napredovanja bolezni (preglednica 1).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
compared with insulin glargine treatment, prolonged-release exenatide treatment significantly lowered mean body weight and was associated with fewer hypoglycaemic events (table 3).
v primerjavi z insulinom glarginom je zdravljenje z eksenatidom v obliki s podaljšanim sproščanjem značilno znižalo srednjo vrednost telesne mase in je bilo povezano z redkejšimi hipoglikemičnimi dogodki (preglednica 3).
Last Update: 2017-04-26
Usage Frequency: 1
Quality: